Skip to main navigation

Top Navigation

Publications
Newsroom
Investors
Blog
Careers
Contact Us

mRNA Technology
COVID-19 Resources
Pipeline
Responsibility
About Us

Investors

IR Navigation

Overview
Stock Information
Corporate Governance
SEC Filings
Events & Presentations
Press Releases
Shareholder Resources
Statements & Perspectives

Investor Relations

Day High

Day Low

Volume

10:26 AM EDT
August 1, 2021

Copyright West LLC.
Minimum 15 minutes Delayed.

Press Releases

July 23, 2021

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union

July 22, 2021

Moderna Announces Establishment of New Charitable Foundation

July 22, 2021

Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023

View All Press Releases

Events

Aug 5, 2021 at 8:00 AM EDT

Moderna 2Q 2021 Earnings Call

Sep 9, 2021 at 8:00 AM EDT

View All Events

Presentations

Corporate Presentation

Vaccines Day Presentation

Annual R&D Day Presentation

Pipeline Program Detail

IR Contact

IR@modernatx.com

Email Alerts

Click Here to have company news delivered to your inbox

mRNA Technology
COVID-19 Resources
Pipeline
Responsibility
About Us

Publications
Newsroom
Investors
Blog
Careers
Contact Us

Facebook
Twitter
Youtube
LinkedIn

Footer Menu - Bottom

© 2021 Moderna, Inc.
Privacy Policy
Join our Mailing List
Terms of Use

×

You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.